MetLife Investment Advisors »

Pliant Therapeutics shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Pliant Therapeutics (PLRX) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Pliant Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Pliant Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pliant Therapeutics by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $540k 30k 18.11
2023-09-30 $517k 30k 17.34
2023-06-30 $540k 30k 18.12
2021-12-31 $128k 9.5k 13.50
2021-09-30 $161k 9.5k 16.88
2021-06-30 $277k 9.5k 29.12
2021-03-31 $374k 9.5k 39.34
2020-12-31 $111k 4.9k 22.77
2020-09-30 $110k 4.9k 22.65